会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 42. 发明授权
    • 항균작용을 갖는 벤즈옥사진 카르복실산 유도체와 그의 제조방법
    • 苯并吖啶甲酸衍生物及其制备方法
    • KR1019910009334B1
    • 1991-11-11
    • KR1019890016019
    • 1989-11-06
    • 한국화학연구원
    • 김완주고광윤이태석김봉진
    • C07D498/06
    • Benzoxazine carboxylic acid derivs. of formula (I) are new. In (I), R1-R5 each = H or lower alkyl; R6 and R7 each = H or C1-3 linear or cyclic lower alkyl, or substd. lower alkyl; the methyl gp. in the 3-position may be (S)-form or racemic form. Also claimed is the prepn. of (I) which comprises condensing a corresp. benzoxazine carboxylic acid deriv. of formula (II) with a 2,5- dihydropyrrole deriv. of formula (III) in the presence or absence of a solvent. Cpds. (I) have a good antibacterial activity and broad spectrum antibacterial action against Gram positive and Gram negative bacteria.
    • 苯并恶嗪羧酸衍生物。 式(I)的化合物是新的。 在(I)中,R 1 -R 5各自为H或低级烷基; R6和R7各自为H或C1-3直链或环状低级烷基,或被取代。 低级烷基 甲基gp。 在3位可以是(S)形式或外消旋形式。 还声称是prepn。 (I),其包括冷凝对应物。 苯并恶嗪羧酸衍生物。 式(II)与2,5-二氢吡咯衍生物反应。 在式(III)的存在或不存在下进行。 CPDS。 (I)对革兰氏阳性和革兰氏阴性菌具有良好的抗菌活性和广谱抗菌作用。
    • 43. 发明授权
    • 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
    • 抗微生物喹啉化合物及其制备方法
    • KR1019910009333B1
    • 1991-11-11
    • KR1019890015203
    • 1989-10-23
    • 한국화학연구원
    • 김완주박명환오종훈정명희김봉진
    • C07D498/04C07D498/06
    • C07D519/00
    • Quinolone derivs. of formula (I) and, when R1 is H, their acid addn. salts and hydrates are new. Z = halo or NH2; R1 = H or a cation. R2 = H, lower alkyl or formyl; m = 1-3; n = 1 or 2. Also claimed is the prepn. of (I) which comprises e.g. condensing corresp. quinolone deriv. with a leaving gp. in the 10-position with a diazabicycloamine. (I) may be orally or parenterally administered at a dose of 0.1-1.5 (0.2-0.8) g/kay to a 60 kg adult. Cpds. (I) are used for the treatment of bacterial infections. (I) have a better and wider range of activity against Gram positive and Gram negative bacteria than existing quinolone antibacterial agents, esp. norfloxacin, ciprofloxacin and ofloxacin. (I) also have a good antibacterial activity against methicillin resistant bacteria.
    • 喹诺酮衍生物。 的式(I)化合物,当R 1为H时,其酸加成。 盐和水合物是新的。 Z =卤素或NH 2; R1 = H或阳离子。 R2 = H,低级烷基或甲酰基; m = 1-3; n = 1或2.还要求是prepn。 的(I),其包含例如 冷凝对应 喹诺酮衍生物 离开gp。 在10位与二氮杂双环胺。 (I)可以以0.1-1.5(0.2-0.8)g / kay的剂量口服或非肠道给药至60kg成人。 CPDS。 (I)用于治疗细菌感染。 (I)比现有的喹诺酮抗菌剂具有更好和更广泛的抗革兰氏阳性和革兰氏阴性菌的活性,特别是。 诺氟沙星,环丙沙星和氧氟沙星。 (I)对耐甲氧西林细菌也具有良好的抗菌活性。
    • 48. 发明公开
    • 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
    • 具有耐药菌株抗菌活性的碳水化合物及其制备方法
    • KR1020030023968A
    • 2003-03-26
    • KR1020010056740
    • 2001-09-14
    • 한국화학연구원
    • 김봉진이철해김재학정희정편도규전미애권지웅김현주
    • C07D477/14
    • Y02P20/55
    • PURPOSE: Provided are carbapenem derivatives represented by formula(1) and a preparation method thereof. The carbapenem derivatives have antibacterial activity against the resistant strains such as methicillin resistant Staphylococcus aureus(MRSA) and resistant strain against Ofloxacin. CONSTITUTION: The method of preparation comprises: reacting a compound of formula(2) with a compound of formula(3) to make an ester derivatives of carbapenem represented by formula(4); and de-protecting carboxy group and hydroxy group. In formula(1), X is S or O atom; Y is hydrogen or halogen atom on a certain location in phenyl group, or C1-2 alkoxy group; M is hydrogen atom or a pair ion forming a pharmaceutically allowable salt. In formula(2,3 and 4), R1 is hydrogen atom or hydroxy protecting group; R2 is carboxy protecting group; X is S or O atom; Y is hydrogen or halogen atom on a certain location in phenyl group.
    • 目的:提供式(1)表示的碳青霉烯衍生物及其制备方法。 碳青霉烯衍生物对抗性菌株如耐甲氧西林金黄色葡萄球菌(MRSA)和耐氧沙星的抗性菌株具有抗菌活性。 构成:制备方法包括:使式(2)化合物与式(3)化合物反应,制得由式(4)表示的碳青霉烯的酯衍生物; 并脱保护羧基和羟基。 在式(1)中,X是S或O原子; Y是苯基或C1-2烷氧基中某一位置上的氢或卤素原子; M是氢原子或形成药学上允许的盐的成对离子。 在式(2,3和4)中,R 1是氢原子或羟基保护基; R2是羧基保护基; X是S或O原子; Y是苯基中某一位置的氢或卤素原子。
    • 49. 发明公开
    • 2-아릴에테닐 카바페넴 유도체 및 그의 제조방법
    • 2-ARYLETHENYL CARBAPENEM衍生物及其制备方法
    • KR1020020006889A
    • 2002-01-26
    • KR1020000040396
    • 2000-07-14
    • 한국화학연구원
    • 이철해김재학정희정편도규곽현정송신섭김은정김봉진정원장
    • C07D205/08
    • PURPOSE: Provided are 2-arylethenyl carbapenem derivative of the formula(1) and its pharmaceutically acceptable salt which have therapeutic effect in methicillin resistant staphylococcus aureus(MRSA) infection. And its manufacturing method and an antibacterial composition containing it as an active ingredient are also provided. CONSTITUTION: 2-arylethenyl carbapenem derivative is represented by the formula(1), wherein R is halogen, nitro, hydroxy or cyano substituted phenyl or fused aryl group; or halogen or C1-3 alkyl group substituted monocyclic, bicyclic or tricyclic 5 or 6 membered hetero aryl group containing at least one of O, S or N atom; and M is hydrogen or zwitterion forming pharmaceutically acceptable salts.
    • 目的:提供式(1)的2-亚乙烯基碳青霉烯衍生物及其药用盐,其在耐甲氧西林金黄色葡萄球菌(MRSA)感染中具有治疗作用。 还提供其制造方法和含有它作为活性成分的抗菌组合物。 构成:2-亚乙烯基碳代青霉烯衍生物由式(1)表示,其中R是卤素,硝基,羟基或氰基取代的苯基或稠合芳基; 或含有O,S或N原子中的至少一个的卤素或C 1-3烷基取代的单环,双环或三环5或6元杂芳基; M是氢或两性离子形成药学上可接受的盐。